{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:22:38Z","timestamp":1767842558395,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00228-010-0944-9","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T06:54:17Z","timestamp":1289804057000},"page":"283-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade"],"prefix":"10.1007","volume":"67","author":[{"given":"Lise","family":"Aagaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Wind","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebba Holme","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"944_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00002018-200831050-00003","volume":"31","author":"M Letourneau","year":"2008","unstructured":"Letourneau M, Wells G, Walop W, Duclos P (2008) Improving global monitoring of vaccines safety. A survey of national centres participating in the WHO programme for international drug monitoring. Drug Saf 31:389\u2013398","journal-title":"Drug Saf"},{"key":"944_CR2","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJMp1000938","volume":"362","author":"E Wendy","year":"2010","unstructured":"Wendy E, Parmet JD (2010) Pandemic vaccines\u2014the legal landscape. N Engl J Med 362:1949\u20131952","journal-title":"N Engl J Med"},{"key":"944_CR3","first-page":"39","volume":"34","author":"KK O\u2019Brien","year":"2009","unstructured":"O\u2019Brien KK (2009) Pharmacists\u2019 role in preventing vaccine-preventable diseases. US Pharm 34:39\u201345","journal-title":"US Pharm"},{"key":"944_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/INF.0b013e3181c40a8a","volume":"29","author":"D Mro\u017cek-Budzyn","year":"2010","unstructured":"Mro\u017cek-Budzyn D, Kie\u0142tyka A, Majewska R (2010) Lack of association between measles\u2013mumps\u2013rubella vaccination and autism in children: a case-control study. Pediatr Infect Dis J 29:397\u2013400","journal-title":"Pediatr Infect Dis J"},{"key":"944_CR5","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa021134","volume":"347","author":"KM Madsen","year":"2002","unstructured":"Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347:1477\u20131482","journal-title":"N Engl J Med"},{"key":"944_CR6","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJMoa032665","volume":"350","author":"A Hviid","year":"2004","unstructured":"Hviid A, Stellfeld M, Wohlfahrt J, Melbye M (2004) Childhood vaccination and type 1 diabetes. N Engl J Med 350:1398\u20131404","journal-title":"N Engl J Med"},{"key":"944_CR7","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/aje\/kwn253","volume":"168","author":"A Hviid","year":"2008","unstructured":"Hviid A, Melbye M (2008) Measles\u2013mumps\u2013rubella vaccination and asthma-like disease in early childhood. Am J Epidemiol 168:1277\u20131283","journal-title":"Am J Epidemiol"},{"key":"944_CR8","doi-asserted-by":"publisher","first-page":"c2829","DOI":"10.1136\/bmj.c2829","volume":"340","author":"E Harris","year":"2010","unstructured":"Harris E (2010) After Wakefield: the real questions that needs addressing. Br Med J 340:c2829","journal-title":"Br Med J"},{"key":"944_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0889-8561(03)00090-0","volume":"23","author":"RM Jacobson","year":"2003","unstructured":"Jacobson RM (2003) Vaccine safety. Immunol Allergy Clin N Am 23:589\u2013603","journal-title":"Immunol Allergy Clin N Am"},{"key":"944_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/00006454-200012000-00002","volume":"19","author":"A Patja","year":"2000","unstructured":"Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H (2000) Serious adverse events after measles\u2013mumps\u2013rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis 19:1127\u20131134","journal-title":"Pediatr Infect Dis"},{"key":"944_CR11","first-page":"270","volume":"110","author":"O Mansoor","year":"1997","unstructured":"Mansoor O, Pillans PI (1997) Vaccine adverse events reported in New Zealand 1990\u20131995. NZ Med J 110:270\u2013272","journal-title":"NZ Med J"},{"key":"944_CR12","first-page":"27","volume":"24","author":"RM D\u2019Souza","year":"2000","unstructured":"D\u2019Souza RM, Campbell-Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F, O'Brien E (2000) Adverse events following immunisation associated with the 1998 Australian measles control campaign. Commun Dis Intell 24:27\u201333","journal-title":"Commun Dis Intell"},{"key":"944_CR13","first-page":"307","volume":"27","author":"G Lawrence","year":"2003","unstructured":"Lawrence G, Menzies R, Burgess M, Wood N, Boyd I, Purcell P, Isaacs D (2003) Surveillance of adverse events following immunisation: Australia, 2000-2002. Commun Dis Intell 27:307\u2013323","journal-title":"Commun Dis Intell"},{"key":"944_CR14","first-page":"324","volume":"28","author":"G Lawrence","year":"2004","unstructured":"Lawrence G, Boyd I, McIntyre P, McIntyre P, Isaacs D (2004) Surveillance of adverse events following immunisation: Australia 2002 to 2003. Commun Dis Intell 28:324\u2013338","journal-title":"Commun Dis Intell"},{"key":"944_CR15","first-page":"413","volume":"29","author":"G Lawrence","year":"2005","unstructured":"Lawrence G, Boyd I (2005) Supplementary report: surveillance of adverse events following immunisation among children aged less than 7\u00a0years in Australia, 1 January to 30 June 2005. Commun Dis Intell 29:413\u2013416","journal-title":"Commun Dis Intell"},{"key":"944_CR16","first-page":"269","volume":"31","author":"GL Lawrence","year":"2007","unstructured":"Lawrence GL, Aratchige PE, Boyd I, McIntyre PB, Gold MS (2007) Annual report on surveillance of adverse events following immunisation in Australia, 2006. Commun Dis Intell 31:269\u2013282","journal-title":"Commun Dis Intell"},{"key":"944_CR17","first-page":"371","volume":"32","author":"G Lawrence","year":"2008","unstructured":"Lawrence G, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre B (2008) Annual report: surveillance of adverse events following immunisation in Australia, 2007. Commun Dis Intell 32:371\u2013387","journal-title":"Commun Dis Intell"},{"key":"944_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/11319100-000000000-00000","volume":"33","author":"L Aagaard","year":"2010","unstructured":"Aagaard L, Weber CB, Hansen EH (2010) Adverse drug reactions reported for children in Denmark from 1998\u20132007. Drug Saf 33:327\u2013339","journal-title":"Drug Saf"},{"issue":"3","key":"944_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1756-0500-3-176","volume":"23","author":"L Aagaard","year":"2010","unstructured":"Aagaard L, Hansen EH (2010) Adverse drug reactions from psychotropic medicines reported for children 1998\u20132007: a national register-based study from Denmark. BMC Res Notes 23(3):176","journal-title":"BMC Res Notes"},{"key":"944_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03732.x","author":"L Aagaard","year":"2010","unstructured":"Aagaard L, Hansen EH (2010) Adverse drug reactions reported for systemic antibacterials in Danish children over a decade. Br J Clin Pharmacol 70:765\u2013768","journal-title":"Br J Clin Pharmacol"},{"key":"944_CR21","unstructured":"The Danish National Board of Health. The children\u2019s vaccination schedule in Denmark, 2009. Available at: (http:\/\/www.sst.dk). Accessed 3 June 2010"},{"key":"944_CR22","unstructured":"Summary of product information. MFR vaccine. Available at: (http:\/\/www.smi.dk). Accessed 3 June 2010"},{"key":"944_CR23","unstructured":"Summary of product information. Ditekipol\/Act-Hib vaccine. Available at: (http:\/\/www.smi.dk). Accessed 3 June 2010"},{"key":"944_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11096-008-9210-y","volume":"30","author":"L Aagaard","year":"2008","unstructured":"Aagaard L, Stenver DI, Hansen EH (2008) Structures and processes in spontaneous reporting systems: a comparative study of Australia and Denmark. Pharm World Sci 30:563\u2013570","journal-title":"Pharm World Sci"},{"key":"944_CR25","doi-asserted-by":"crossref","unstructured":"Roden S, Gibbs T (2007) CIOMS Working Groups and their contribution to pharmacovigilance. In: Mann RD, Andrews EB (eds) Pharmacovigilance, 2nd edn, chapter 23. John Wiley & Sons, Chichester, pp 287\u2013305","DOI":"10.1002\/9780470059210.ch23"},{"key":"944_CR26","unstructured":"MedDRA. Available at: http:\/\/www.meddramsso.com (last accessed June 3 2010) [password required]"},{"key":"944_CR27","unstructured":"Pharmacovigilance: medicinal products for human use and veterinary products, vol. 9. Available at: http:\/\/ec.europa.eu\/enterprise\/pharmaceuticals\/eudralex\/homev9.htm. Accessed 3 April 2010"},{"key":"944_CR28","unstructured":"Infomedia. Available at: http:\/\/www.infomedia.dk. Accessed 20 November 2009"},{"key":"944_CR29","first-page":"E050428.3","volume":"10","author":"S Glissman","year":"2005","unstructured":"Glissman S (2005) Danish Supreme Court rules that child with autism developed in temporal relation with MMR vaccination is not entitled to compensation. Euro Surveill 10:E050428.3","journal-title":"Euro Surveill"},{"key":"944_CR30","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.vaccine.2005.09.019","volume":"27","author":"A Hviid","year":"2006","unstructured":"Hviid A, Stellfeld M, Wohlfahrt J, Andersen PH, Melbye M (2006) The impact of pre-school booster vaccination of 4\u20136-year-old children on pertussis in 0\u20131-year-old children. Vaccine 27:1401\u20131407","journal-title":"Vaccine"},{"issue":"9","key":"944_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6904-9-4","volume":"3","author":"L Aagaard","year":"2009","unstructured":"Aagaard L, Hansen EH (2009) Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol 3(9):4","journal-title":"BMC Clin Pharmacol"},{"key":"944_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2165\/00002018-200831080-00003","volume":"31","author":"EJ Woo","year":"2008","unstructured":"Woo EJ, Ball R, Burwen DR, Braun MM (2008) Effects of stratification on data mining in the US Vaccine adverse event reporting system (VAERS). Drug Saf 31:667\u2013674","journal-title":"Drug Saf"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0944-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-010-0944-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0944-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0944-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T15:46:20Z","timestamp":1659109580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-010-0944-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1007\/s00228-010-0944-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,16]]},"assertion":[{"value":"11 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}